Skip to main content
Premium Trial:

Request an Annual Quote

Gates Foundation Supports Fast Track Development of Proteome Systems TB Diagnostic

NEW YORK, June 21 (GenomeWeb News) - The Foundation for Innovative New Diagnostics, which is funded by the Bill & Melinda Gates Foundation, said that it has signed a letter of intent with Australian biotech Proteome Systems to "fast track" the development of a rapid antigen-based diagnostic test for active tuberculosis.


FIND announced the collaboration today at BIO 2005 in Philadelphia.


Proteome Systems' test is expected to detect TB antigens indicating active TB infection in the human body. The test will also monitor disease progression and response to treatment in TB patients regardless of the immune status of the host, FIND said.


Stephen Porges, Proteome Systems' CEO, said that the partnership with FIND "will provide the critical support to speed the development of the test in addition to clinical material, assistance with clinical trials and fast tracking of registration, in return for exclusive royalty-free rights to distribute the product in the public health sector in developing countries."

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.